Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
5.31
+0.21 (4.12%)
Aug 10, 2026, 4:00 PM EDT - Market closed
Jupiter Neurosciences Employees
Jupiter Neurosciences had 5 employees as of December 31, 2025. The number of employees increased by 1 or 25.00% compared to the previous year.
Employees
5
Change (1Y)
1
Growth (1Y)
25.00%
Revenue / Employee
$8,090
Profits / Employee
-$1,835,598
Market Cap
3.07M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 5 | 1 | 25.00% |
| Dec 31, 2024 | 4 | 0 | - |
| Jun 30, 2024 | 4 | - | - |
| Mar 31, 2024 | 4 | - | - |
| Dec 31, 2023 | 4 | -1 | -20.00% |
| Sep 30, 2022 | 5 | 0 | - |
| Jun 30, 2022 | 5 | 0 | - |
| Mar 31, 2022 | 5 | 0 | - |
| Sep 30, 2021 | 5 | - | - |
| Jun 30, 2021 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Virax Biolabs Group | 26 |
| TransCode Therapeutics | 12 |
| Artelo Biosciences | 7 |
| Galmed Pharmaceuticals | 6 |
| GRI Bio | 4 |
| 60 Degrees Pharmaceuticals | 3 |
| Oragenics | 3 |
| SciSparc | 3 |
JUNS News
- 4 days ago - Jupiter Neurosciences Inc trading halted, news pending - TheFly
- 5 days ago - Jupiter Neurosciences announces 1-for-75 reverse stock split - TheFly
- 5 days ago - Jupiter Neurosciences, Inc. Announces Reverse Stock Split - GlobeNewsWire
- 18 days ago - Psychedelic: PharmAla enters license agreement with Jupiter Neurosciences - TheFly
- 20 days ago - Jupiter Neurosciences Stock (JUNS) Jumps on a New License Deal - TipRanks
- 20 days ago - PharmAla enters up to $100M ALA-002 license pact with Jupiter Neurosciences - TheFly
- 20 days ago - Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million - GlobeNewsWire
- 4 weeks ago - Jupiter Neurosciences Strengthens Board with Appointment of Dr. Tomas J. Philipson - GlobeNewsWire